Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial

Kasper Korsholm,Dorte Damgaard,Jan Brink Valentin,Erik Jerome Stene Packer,Jacob Odenstedt,Juha Sinisalo,Jukka Putaala,Halvor Næss, Mohammad Ahmad Al-Jazi, Jan-Erik Karsson,Jacob Pontoppidan,Boris Modrau,Jakob Hjort,Kristina Laut Matzen,Søren Paaske Johnsen,Jens Erik Nielsen-Kudsk

American Heart Journal（2022）

引用 9|浏览45

暂无评分

摘要

The Occlusion-AF trial is designed to compare LAAO to NOAC therapy for secondary stroke prevention in AF patients with a high risk of recurrent thromboembolic events, i.e. with previous ischemic stroke or TIA, and otherwise eligible for anticoagulation. The results are expected to contribute significantly to the understanding of the effects of LAAO compared to the standard contemporary pharmacological treatment in these patients.

查看译文

关键词

Left atrial appendage occlusion,atrial fibrillation,oral anticoagulation,stroke prevention

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要